We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
301
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $15.5M | 0.04% |
102,726
| – | – |
|
302
Crown Holdings
CCK
$12.9B
| $15.4M | 0.04% |
190,440
+22,475
| +13% | +$2.1M |
|
303
Northrop Grumman
NOC
$77.8B
| $15.4M | 0.04% |
32,705
+24,730
| +310% | +$11.8M |
|
304
Cleveland-Cliffs
CLF
$6.99B
| $15.2M | 0.04% |
1,124,685
+146,200
| +15% | +$2.43M |
|
305
SS&C Technologies
SSNC
$18.1B
| $15.1M | 0.04% |
317,175
-6,825
| -2% | -$393K |
|
306
L3Harris
LHX
$56.5B
| $15M | 0.04% |
71,991
+65,195
| +959% | +$15M |
|
307
Evergy
EVRG
$19.8B
| $14.9M | 0.04% |
251,336
+6,030
| +2% | +$406K |
|
308
Steel Dynamics
STLD
$36.1B
| $14.8M | 0.04% |
209,194
-48,470
| -19% | -$3.67M |
|
309
DTE Energy
DTE
$30.6B
| $14.8M | 0.04% |
128,970
-18,550
| -13% | -$2.4M |
|
310
Paychex
PAYX
$41.1B
| $14.8M | 0.04% |
132,172
+5,445
| +4% | +$675K |
|
311
TE Connectivity
TEL
$60.2B
| $14.7M | 0.04% |
133,490
+3,295
| +3% | +$410K |
|
312
Consolidated Edison
ED
$41.1B
| $14.6M | 0.04% |
170,387
+41,160
| +32% | +$3.97M |
|
313
Datadog
DDOG
$89.7B
| $14.5M | 0.04% |
162,892
+89,343
| +121% | +$9M |
|
314
Sarepta Therapeutics
SRPT
$1.68B
| $14.4M | 0.04% |
130,610
+110,080
| +536% | +$11.1M |
|
315
Best Buy
BBY
$18.6B
| $14.2M | 0.04% |
224,801
-9,282
| -4% | -$687K |
|
316
MarketAxess Holdings
MKTX
$4.19B
| $14.2M | 0.04% |
63,751
-5,356
| -8% | -$1.37M |
|
317
UGI
UGI
$7.91B
| $14M | 0.03% |
433,211
-24,765
| -5% | -$977K |
|
318
Advance Auto Parts
AAP
$3.48B
| $14M | 0.03% |
89,482
+1,960
| +2% | +$358K |
|
319
Equifax
EFX
$20.8B
| $13.9M | 0.03% |
81,045
+44,510
| +122% | +$8.72M |
|
320
National Fuel Gas
NFG
$7.67B
| $13.8M | 0.03% |
224,108
+3,645
| +2% | +$251K |
|
321
Cytokinetics
CYTK
$10.9B
| $13.7M | 0.03% |
283,369
+45,600
| +19% | +$2.19M |
|
322
Cognizant
CTSH
$22.3B
| $13.7M | 0.03% |
237,825
+26,605
| +13% | +$1.74M |
|
323
Ameriprise Financial
AMP
$47.6B
| $13.6M | 0.03% |
54,070
+10,050
| +23% | +$2.64M |
|
324
Graco
GGG
$13B
| $13.6M | 0.03% |
227,143
+42,932
| +23% | +$2.75M |
|
325
WEC Energy
WEC
$37.1B
| $13.6M | 0.03% |
151,913
+47,865
| +46% | +$4.89M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.